This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $13,796.78 order is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has a ceiling value of $4,266.10 and is a firm-fixed-price delivery order, with a completion date of May 30, 2025. The contract is not set aside for any small business program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $14,387.84 Firm Fixed Price Delivery Order is for the supply of RUXIENCE 100 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a period of performance through July 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $9,457.40 contract is for the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that was awarded solely to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $4,728.70 contract is for the delivery of RUXIENCE 500 MG/50 ML vial medication with an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp holds a single award indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a $19,118.40 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RUXIENCE 500 MG/50 ML VIAL 50ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
This is a $1,944.73 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a medical product, with a completion date of January 10, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML, with a firm fixed price ceiling of $4,892.20 and a period of performance through June 11, 2025. This delivery order is not associated with a set-aside program. AmerisourceBergen Drug Corporation holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania. The contract is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, with a ceiling value of $11,348.88 and a period of performance through March 25, 2024. AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen...
This is a $6,359.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RUXIENCE 500 mg/50 ml vials and has an ultimate completion date of January 16, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical for providing a...